Cavitation Technologies, Inc. Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost
Cavitation Technologies, Inc. (CVAT) had Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost of $1.02 million as of 2025-06-30, per its 10-K filed 2025-09-29.
Financial Statements › Notes › Income Taxes › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost · last filed 2025-09-29
- 2025-06-30: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $1.02M.
- 2024-06-30: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $962.00K.
- 2023-06-30: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $962.00K.
- 2022-06-30: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $938.00K.
| Period end | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost |
|---|---|
| 2025-06-30 | $1.02M 10-K · filed 2025-09-29 |
| 2024-06-30 | $962.00K 10-K · filed 2025-09-29 |
| 2023-06-30 | $962.00K 10-K · filed 2024-09-30 |
| 2022-06-30 | $938.00K 10-K · filed 2023-10-03 |
| 2021-06-30 | $840.00K 10-K/A · filed 2023-02-10 |
| 2020-06-30 | $840.00K 10-K · filed 2021-10-13 |
| 2019-06-30 | $783.00K 10-K · filed 2020-10-13 |
| 2018-06-30 | $658.00K 10-K · filed 2019-10-15 |
| 2016-06-30 | $725.00K 10-K · filed 2016-10-13 |
| 2013-06-30 | $2.50M 10-K · filed 2013-10-15 |
| 2012-06-30 | $2.50M 10-K · filed 2013-10-15 |